Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05572463
Title A Platform Study of Novel Immunotherapy Products in Participants With Previously Treated Unresectable or Metastatic Cutaneous Melanoma
Recruitment Withdrawn
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Innovent Biologics (Suzhou) Co. Ltd.
Age Groups: adult | senior
Covered Countries USA | GBR | FRA | ESP | DEU | AUS

Facility Status City State Zip Country Details
University of California San Francisco Medical Center San Francisco California 94143 United States Details
Henry Ford Hospital Detroit Michigan 48202 United States Details
Hackensack University Medical Center Hackensack New Jersey 07601 United States Details
Princess Victoria Hospital Woolloongabba Queensland 4102 Australia Details
Hospices Civil De Lyon Nord - Centre Hospitalier Lyon Sud - Dermatologie Lyon 69002 France Details
Hospital Saint Louis Paris 75010 France Details
Universitatsklinikum Carl Gustav Carus Dresden 01307 Germany Details
Universitatsklinikum Essen Essen 45147 Germany Details
Institut Catala d'Oncologia Hospital Universitari Germans Trials I Pujol, Barcelona Barcelona 8916 Spain Details
Hospital Universitario Reina Sofia, Cordoba Córdoba 14004 Spain Details
Universitaets Spital Zurich Zürich 8091 Switzerland Details
Cambridge University Hospitals NHS Foundation Trust (Oxford) Cambridge CB2 0QQ United Kingdom Details
Lancashire Teaching Hospitals (Preston) Preston PR2 9HT United Kingdom Details
*Shaded cells indicate that there was no data available from for the field